Trial Profile
Angioscopic evaluation of coronary atherosclerotic plaque after revascularization with drug-eluting stent - Intervention trial with statins and cholesterol absorption inhibitors -
Status:
Discontinued
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Pravastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hyperlipidaemia; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms ANTARES
- 08 Apr 2013 New trial record